Brenus Pharma secures funding to advance cancer vaccine trials
Brenus Pharma has completed a Series A funding round, securing $25m to propel the clinical trials of its precision cancer vaccines. Angelor led the financing round with contributions from Belgian funds Noshaq and Investsud. BIOJAG co-founder Jacques …